J. Hirsh

23.3k citations

297 papers · 17.5k indexed · 8 hit papers · h-index 67

Impact in

Internal Medicine top 0.01%
- Venous Thromboembolism Diagnosis and Management
Hematology top 0.1%
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments

Papers in

Internal Medicine 133
- Venous Thromboembolism Diagnosis and Management 133
Hematology 90
- Blood Coagulation and Thrombosis Mechanisms 61
- Platelet Disorders and Treatments 30

Co-authors: Michael Gent Levine Mn Jeffrey I. Weitz Michael R. Buchanan MN Levine Alexander Gallus David R. Anderson John M. Maraganore
Journals: Thrombosis and Haemostasis (33 papers)Blood (32 papers)Thrombosis Research (31 papers)British Journal of Haematology (14 papers)Journal of Thrombosis and Haemostasis (14 papers)
Partner nations: Canada Australia United States

In The Last Decade

J. Hirsh

291 papers receiving 15.9k citations

Hit Papers

8 papers align trajectories log scale

Medical device‐induced thrombosis: what causes it and how can we prevent it? 2015 · 424 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Journal of Thrombosis and Haemostasis
2001 CHEST Journal
1998 Annals of Internal Medicine
1992 Blood
1992 Blood
1990 Journal of Clinical Investigation
1983 Annals of Internal Medicine
1982 New England Journal of Medicine

Peers

Countries citing papers authored by J. Hirsh

Since Specialization

Citations

This map shows the geographic impact of J. Hirsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Hirsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Hirsh more than expected).

Fields of papers citing papers by J. Hirsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Hirsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Hirsh. The network helps show where J. Hirsh may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Hirsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Hirsh Line = papers co-authored together J. Hirsh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials BMJ ·Florent Boutitie, L. Pinède, Sam Schulman, Giancarlo Agnelli, Gary E. Raskob, Jim A. Julian, J. Hirsh, C. Kearon	2011	246
2	Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial Journal of Thrombosis and Haemostasis ·Julia A. M. Anderson, J. Hirsh, Salim Yusuf, Marilyn Johnston, R. Afzal, Shamir R. Mehta, Keith A.A. Fox, Andrzej Budaj, John W. Eikelboom	2009	29
3	Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery Journal of Thrombosis and Haemostasis ·Daniel J. Quinlan, John W. Eikelboom, O.E. Dahl, Bengt I. Eriksson, Paul S. Sidhu, J. Hirsh	2007	85
4	Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture Circulation ·Michael Gent, J. Hirsh, JS Ginsberg, P Powers, M.N. Levine, William Geerts, RichardM Jay, Jacques Leclerc, Jean Neemeh, Alexander G.G. Turpie	1996	83
5	In vitro effect of hirudin on recalcification time. PubMed Central ·J. Hirsh, Charles R. Spillert, E. P. Delle Donne, E. J. Lazaro	1994	3
6	Anticoagulant and platelet antiaggregant agents Stroke ·J. Hirsh	1986	1
7	Management of anti-thrombin III deficiency during pregnancy without administration of anti-thrombin III Thrombosis Research ·Jacques R. Leclerc, William Geerts, Akbar Panju, Philip V. Nguyen, J. Hirsh	1986	18
8	In vivo activity of a new heparinoid Pathology ·Paul Ockelford, C.J. Carter, J. Hirsh	1985	7
9	PLATELET SUPPRESSIVE THERAPY British Medical Bulletin ·A. G. G. Turpie, J. Hirsh	1978	14
10	Increased heparin clearance in experimental pulmonary embolism. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·HM Chiu, van Aken Wg, J. Hirsh, E. Regoeczi, Horner Aa	1977	16
11	Increased Heparin Clearance in Experimental Pulmonary Embolism Thrombosis and Haemostasis ·W.G. van Aken, Hsiang-Yu Lin Hsiao-Yu Chiu, J. Hirsh, E. Regoeczi, A A Horner	1977	11
12	Normalization of Platelet Survival in an Experimental Model after Platelet Exposure of Thrombin in Vitro or adp in Vivo Thrombosis and Haemostasis ·D.G. Meuleman, Michael R. Buchanan, Alan R. Giles, J. Hirsh	1977	1
13	Treatment of venous thromboembolic disease. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Alexander Gallus, J. Hirsh	1976	36
14	Effects of methyl prednisolone on platelet adhesion to damaged aorta bleeding time and platelet survival Blood ·J A Davies, Andrew F. Senyi, M. A. Blajchman, J. Hirsh, J F Mustard	1976	7
15	Critical evaluation of platelet-inhibiting drugs in thrombotic disease. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Harker La, J. Hirsh, Michael Gent, Edward Genton	1975	9
16	Low dose heparin prophylaxis in elective surgery: A randomized study Circulation ·Alexander Gallus, J. Hirsh	1974	1
17	Clinical Experience with Anticoagulant Therapy During Pregnancy BMJ ·J. Hirsh, J. F. Cade, E. F. O'Sullivan	1970	79
18	Placental Barrier to Coagulation Factors: Its Relevance to the Coagulation Defect at Birth and to Haemorrhage in the Newborn BMJ ·J. F. Cade, J. Hirsh, Mary Beth Martin	1969	62
19	HYPOFIBRINOGENÆMIA WITHOUT INCREASED FIBRINOLYSIS IN LEUKÆMIA The Lancet ·J. Hirsh, J. G. Buchanan, G. C. de Gruchy, A.G. Baikie	1967	24
20	Increased platelet adhesiveness in recurrent venous thrombosis and pulmonary embolism. BMJ ·J. Hirsh, J. A. McBride	1965	60

About J. Hirsh

J. Hirsh is a scholar working on Internal Medicine, Hematology, Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine and Surgery, having authored 297 papers that have together received 17.5k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (133 papers), Blood Coagulation and Thrombosis Mechanisms (61 papers), Atrial Fibrillation Management and Outcomes (56 papers), Antiplatelet Therapy and Cardiovascular Diseases (50 papers), Heparin-Induced Thrombocytopenia and Thrombosis (46 papers), Blood properties and coagulation (32 papers), Platelet Disorders and Treatments (30 papers) and Protease and Inhibitor Mechanisms (20 papers). The work is most often cited by research in Internal Medicine (9.0k citations), Hematology (4.9k citations), Cardiology and Cardiovascular Medicine (8.2k citations), Critical Care and Intensive Care Medicine (827 citations) and Emergency Medical Services (1.1k citations). J. Hirsh has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Michael Gent, Levine Mn, Jeffrey I. Weitz, Michael R. Buchanan, MN Levine, Alexander Gallus, David R. Anderson, John M. Maraganore, James E. Dalen and David Massel. Their work appears in journals such as Thrombosis and Haemostasis, Blood, Thrombosis Research, British Journal of Haematology and Journal of Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact